Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

380 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comprehensive Molecular, Pathological, and Clinical Characterization of Clear Cell Adenocarcinoma of the Urinary Tract.
Rammal R, Koll FJ, Chen Z, Tallman JE, Alam SM, Eichholz J, Chatila W, Agbamu T, Lenis AT, Basar M, Yol C, Chen JF, Sarungbam J, Chen Y, Gopalan A, Fine SW, Tickoo SK, Antonescu CR, Weigelt B, Abu-Rustum NR, Grisham RN, Momeni-Boroujeni A, Pietzak EJ, Bochner BH, Rosenberg JE, Iyer G, Reuter VE, Solit DB, Al-Ahmadie H. Rammal R, et al. Among authors: solit db. Mod Pathol. 2025 Jun 17:100821. doi: 10.1016/j.modpat.2025.100821. Online ahead of print. Mod Pathol. 2025. PMID: 40553939
Genomic landscape of inverted urothelial papilloma and urothelial papilloma of the bladder.
Isharwal S, Hu W, Sarungbam J, Chen YB, Gopalan A, Fine SW, Tickoo SK, Sirintrapun SJ, Jadallah S, Loo FL, Pietzak EJ, Cha EK, Bochner BH, Berger MF, Iyer G, Solit DB, Reuter VE, Al-Ahmadie H. Isharwal S, et al. Among authors: solit db. J Pathol. 2019 Jul;248(3):260-265. doi: 10.1002/path.5261. Epub 2019 Apr 22. J Pathol. 2019. PMID: 30838648 Free PMC article.
Differential NEUROD1, ASCL1, and POU2F3 Expression Defines Molecular Subsets of Bladder Small Cell/Neuroendocrine Carcinoma With Prognostic Implications.
Akbulut D, Whiting K, Teo MY, Tallman JE, Ozcan GG, Basar M, Jia L, Rammal R, Chen JF, Sarungbam J, Chen YB, Gopalan A, Fine SW, Tickoo SK, Mehra R, Baine M, Bochner BH, Pietzak EJ, Bajorin DF, Rosenberg JE, Iyer G, Solit DB, Reuter VE, Rekhtman N, Ostrovnaya I, Al-Ahmadie H. Akbulut D, et al. Among authors: solit db. Mod Pathol. 2024 Oct;37(10):100557. doi: 10.1016/j.modpat.2024.100557. Epub 2024 Jul 2. Mod Pathol. 2024. PMID: 38964503
Somatic mutation of fibroblast growth factor receptor-3 (FGFR3) defines a distinct morphological subtype of high-grade urothelial carcinoma.
Al-Ahmadie HA, Iyer G, Janakiraman M, Lin O, Heguy A, Tickoo SK, Fine SW, Gopalan A, Chen YB, Balar A, Riches J, Bochner B, Dalbagni G, Bajorin DF, Reuter VE, Milowsky MI, Solit DB. Al-Ahmadie HA, et al. Among authors: solit db. J Pathol. 2011 Jun;224(2):270-9. doi: 10.1002/path.2892. Epub 2011 May 5. J Pathol. 2011. PMID: 21547910 Free PMC article.
Genomic Characterization of Upper Tract Urothelial Carcinoma.
Sfakianos JP, Cha EK, Iyer G, Scott SN, Zabor EC, Shah RH, Ren Q, Bagrodia A, Kim PH, Hakimi AA, Ostrovnaya I, Ramirez R, Hanrahan AJ, Desai NB, Sun A, Pinciroli P, Rosenberg JE, Dalbagni G, Schultz N, Bajorin DF, Reuter VE, Berger MF, Bochner BH, Al-Ahmadie HA, Solit DB, Coleman JA. Sfakianos JP, et al. Among authors: solit db. Eur Urol. 2015 Dec;68(6):970-7. doi: 10.1016/j.eururo.2015.07.039. Epub 2015 Aug 14. Eur Urol. 2015. PMID: 26278805 Free PMC article.
Prognostic Value of TERT Alterations, Mutational and Copy Number Alterations Burden in Urothelial Carcinoma.
Isharwal S, Audenet F, Drill E, Pietzak EJ, Iyer G, Ostrovnaya I, Cha E, Donahue T, Arcila M, Jayakumaran G, Berger MF, Rosenberg JE, Bajorin DF, Coleman J, Dalbagni G, Reuter VE, Bochner BH, Solit DB, Al-Ahmadie HA. Isharwal S, et al. Among authors: solit db. Eur Urol Focus. 2019 Mar;5(2):201-204. doi: 10.1016/j.euf.2017.07.004. Epub 2017 Aug 10. Eur Urol Focus. 2019. PMID: 28802642 Free PMC article.
Intratumoral heterogeneity of ERBB2 amplification and HER2 expression in micropapillary urothelial carcinoma.
Isharwal S, Huang H, Nanjangud G, Audenet F, Chen YB, Gopalan A, Fine SW, Tickoo SK, Lee BH, Iyer G, Chadalavada K, Rosenberg JE, Bajorin DF, Herr HW, Donat SM, Dalbagni G, Bochner BH, Solit DB, Reuter VE, Al-Ahmadie HA. Isharwal S, et al. Among authors: solit db. Hum Pathol. 2018 Jul;77:63-69. doi: 10.1016/j.humpath.2018.03.015. Epub 2018 Mar 27. Hum Pathol. 2018. PMID: 29601842 Free PMC article.
PD-L1 Expression in Urothelial Carcinoma With Predominant or Pure Variant Histology: Concordance Among 3 Commonly Used and Commercially Available Antibodies.
Reis H, Serrette R, Posada J, Lu V, Chen YB, Gopalan A, Fine SW, Tickoo SK, Sirintrapun SJ, Iyer G, Funt SA, Teo MY, Rosenberg JE, Bajorin DF, Dalbagni G, Bochner BH, Solit DB, Reuter VE, Al-Ahmadie HA. Reis H, et al. Among authors: solit db. Am J Surg Pathol. 2019 Jul;43(7):920-927. doi: 10.1097/PAS.0000000000001264. Am J Surg Pathol. 2019. PMID: 31135485 Free PMC article.
CD274 (PD-L1) Copy Number Changes (Gain) & Response to Immune Checkpoint Blockade Therapy in Carcinomas of the Urinary Tract.
Gupta S, Vanderbilt CM, Zhang Y, Tickoo SK, Fine SW, Gopalan A, Chen YB, Sirintrapun SJ, Teo MY, Funt SA, Iyer G, Rosenberg JE, Bajorin DF, Bochner BH, Pietzak EJ, Ross DS, Ladanyi M, Cheville JC, Solit DB, Reuter VE, Al-Ahmadie HA. Gupta S, et al. Among authors: solit db. Bladder Cancer. 2021;7(4):395-400. doi: 10.3233/blc-201532. Epub 2021 Dec 13. Bladder Cancer. 2021. PMID: 35071713 Free PMC article.
380 results